21 CFR 888.3041
§ 888.3041 Absorbable metallic bone fixation fastener.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 888.3041, § 888.3041 Absorbable metallic bone fixation fastener, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/91062
- Permanent ID
ys:prov:91062@1- SHA-256
227caa56bf15f31451a15ad7d8d40a7b7f62549e484f789f57923c70e94eb033
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Identification. An absorbable metallic bone fixation fastener is an implant, such as a bone screw, pin, or Kirschner wire, composed of one or more absorbable metal or metal alloys and intended to provide rigid bone fixation suitable for osteosynthesis. The device is designed to fully absorb after osteosynthesis is achieved.
(b) Classification. Class II (special controls). The special controls for this device are:
(1) Clinical data must demonstrate that the device performs as intended under the anticipated conditions of use. The absorption profile must be characterized to completion (full absorption). The difficulty of any revision surgeries must be documented.
(2) Non-clinical performance testing must demonstrate that the product performs as intended under anticipated conditions of use. Testing must:
(i) Evaluate the complete degradation profile of the device;
(ii) Evaluate the initial mechanical performance; and
(iii) Evaluate the mechanical performance as the device degrades.
(3) The device must be demonstrated to be biocompatible.
(4) The device must be demonstrated to be non-pyrogenic.
(5) Performance data must demonstrate the sterility of the device.
(6) Performance data must support the labeled shelf-life of the device by demonstrating continued sterility, package integrity, and device functionality (i.e., degradation profile and mechanical performance) over the established shelf life.
(7) Labeling must include:
(i) Material composition;
(ii) Absorption byproducts;
(iii) A detailed summary of the product's technical parameters;
(iv) An expiration date/shelf life;
(v) Instructions for revision surgery;
(vi) Time to complete absorption; and
(vii) A summary of clinical data with the device.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.